Miller Larry Lee reported acquisition or exercise transactions in this Form 4 filing.
Phibro Animal Health Corp reported that Chief Operating Officer Larry Lee Miller received a grant of 3,522 restricted stock units (RSUs) representing Class A Common Stock on August 6, 2026. These RSUs vest in three substantially equal installments on the first three anniversaries of August 1, 2026, contingent on his continued employment. Following this award, Miller directly holds 38,071 shares of Class A Common Stock, including the RSUs.
BENDHEIM Jonathan reported acquisition or exercise transactions in this Form 4 filing.
PHIBRO ANIMAL HEALTH CORP reported that director Jonathan Bendheim received a grant of 2,716 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. Following this award, his directly held Class A Common Stock position is 5,984 shares.
The RSUs are scheduled to vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment through each applicable vesting date.
Weinstein Judith reported acquisition or exercise transactions in this Form 4 filing.
Phibro Animal Health Corp reported an equity compensation award to senior vice president and general counsel Judith Weinstein. She received 2,478 restricted stock units, each representing one share of Class A Common Stock, increasing her direct holdings to 5,453 shares. The RSUs vest in substantially equal installments over three years starting on August 1, 2026, conditioned on continued employment through each vesting date.
BENDHEIM JACK reported acquisition or exercise transactions in this Form 4 filing.
Phibro Animal Health Corp reported that Executive Chairman and 10% owner Jack Bendheim received a grant of 12,103 restricted stock units (RSUs), each representing one share of Class A Common Stock. These RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment. Following the award, Bendheim directly holds 26,640 Class A shares and is also reported as having shared voting and investment power over 56,152 Class A shares held by BFI Co., LLC, while disclaiming beneficial ownership beyond his pecuniary interest.
Escudero Lisa Ann reported acquisition or exercise transactions in this Form 4 filing.
PHIBRO ANIMAL HEALTH CORP Senior Vice President of Human Resources Lisa Ann Escudero received a grant of 1,547 restricted stock units (RSUs) of Class A Common Stock on 2026-08-06. The RSUs vest in three substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to continued employment. Following this award, Escudero directly holds 3,434 shares (or share-equivalent RSUs) of Class A Common Stock.
PHIBRO ANIMAL HEALTH CORP reported an equity compensation grant to President and CEO Daniel M. Bendheim. He acquired 11,699 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment. Following this award, Bendheim directly holds 15,177 shares of Class A Common Stock, including the RSUs.
PHIBRO ANIMAL HEALTH CORP Executive Chairman and 10% owner Jack Bendheim reported the disposition of 2,303 shares of Class A Common Stock on August 4, 2026. According to the disclosure, these shares were sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the vesting and settlement of restricted stock units. Following this transaction, Bendheim directly holds 14,537 Class A shares, and an affiliated entity, BFI Co., LLC, holds 56,152 shares over which he exercises voting and dispositive power while disclaiming beneficial ownership except for his pecuniary interest.
Phibro Animal Health Corp officer Lisa Ann Escudero, Senior Vice President of Human Resources, had 265 shares of Class A Common Stock disposed of on August 4, 2026, at $36.599 per share in a broker-assisted cashless transaction to satisfy tax withholding on vested RSUs, leaving 1,887 shares held directly.
Phibro Animal Health Chief Operating Officer Larry Lee Miller reported a disposition of 635 shares of Class A Common Stock on August 4, 2026. The shares were sold at $36.599 per share in a broker-assisted cashless exercise to satisfy tax withholding obligations related to restricted stock unit vesting. Following the transaction, he directly held 34,549 shares.
PHIBRO ANIMAL HEALTH CORP executive Judith Weinstein reported an other disposition of 472 shares of Class A Common Stock on August 4, 2026, at $36.599 per share. According to the filing, these shares were sold in a broker-assisted cashless exercise to satisfy tax withholding obligations upon vesting and settlement of restricted stock units. Following this transaction, Weinstein directly held 2,975 shares of Class A Common Stock. The transaction was not reported as occurring under a Rule 10b5-1 trading plan.